4.4 Article

18F-fluorocholine PET/MRI versus ultrasound and sestamibi for the localization of parathyroid adenomas

Journal

LANGENBECKS ARCHIVES OF SURGERY
Volume 408, Issue 1, Pages -

Publisher

SPRINGER
DOI: 10.1007/s00423-023-02893-6

Keywords

Primary hyperparathyroidism; [F-18]-fluorocholine PET; Magnetic resonance imaging; Nuclear imaging; Parathyroid; Parathyoidectomy

Categories

Ask authors/readers for more resources

This study compared the diagnostic value of standard-of-care localization techniques to FCH-PET/MRI in primary hyperparathyroidism. The results showed that FCH-PET/MRI is a highly accurate imaging modality for localization of parathyroid adenomas and is superior to other techniques.
PurposeAccurate preoperative localization is imperative to facilitate a minimally invasive parathyroidectomy (MIP) in primary hyperparathyroidism (pHPT). This study aims to compare the diagnostic value of standard-of-care localization techniques (ultrasound [US] and (99m)Technetium (Tc-99m) -sestamibi scintigraphy) to [F-18]-fluorocholine positron emission tomography/magnetic resonance imaging (FCH-PET/MRI) to determine the additional clinical usefulness of PET/MRI in a Canadian cohort.MethodsWe conducted a prospective, appropriately powered, study to compare the diagnostic value of -FCH PET/MRI to that of the US and Tc-99m-sestamibi scintigraphy for localization of parathyroid adenomas in a patient with pHPT. The primary outcome was the per-lesion sensitivity and positive predictive value (PPV) of FCH-PET/MRI, US, and Tc-99m-sestamibi scintigraphy. Intraoperative surgeon localization, parathormone levels, and histopathological findings were used as reference standards.ResultsForty-one patients underwent FCH-PET/MRI of which 36 patients had parathyroidectomy. In these 36 patients, 41 parathyroid lesions were histologically confirmed as adenomas or hyperplastic glands. Per-lesion sensitivity of FCH-PET/MRI was 82.9% and of US and Tc-99m-sestamibi scintigraphy combined at 50.0%, respectively. The sensitivity of FCH-PET/MRI was superior to that of US and Tc-99m-sestamibi scintigraphy (p = 0.002). In the 19 patients in whom both US and Tc-99m-sestamibi scintigraphy were negative, PET/MRI correctly identified the parathyroid adenoma in 13 patients (68%).ConclusionsFCH-PET/MRI is a highly accurate imaging modality for localization of parathyroid adenomas in a tertiary center in North America. It is a superior functional imaging modality to Tc-99m-sestamibi scintigraphy alone and more sensitive for localization of parathyroid lesions than US and Tc-99m-sestamibi scintigraphy combined. This imaging modality could become the most valuable preoperative localization study given its superior performance in localizing parathyroid adenomas.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available